* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download General Issues
5-HT3 antagonist wikipedia , lookup
Toxicodynamics wikipedia , lookup
5-HT2C receptor agonist wikipedia , lookup
Compounding wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
Pharmacogenomics wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Cannabinoid receptor antagonist wikipedia , lookup
Nicotinic agonist wikipedia , lookup
Pharmacognosy wikipedia , lookup
Drug discovery wikipedia , lookup
Theralizumab wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Prescription costs wikipedia , lookup
Drug design wikipedia , lookup
Drug interaction wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Psychopharmacology (psychoactive drugs) 1. Name ways to get a drug into your system (sources of drug administration) 2. Rank those sources based on how fast they reach blood & thus the brain 3. List the factors that determine the effect of a drug on an individual. (In other words, what makes a psychoactive drug be more effective in one person than another) Outline • Pharmacokinetics – Dose-response curve • Pharmacodynamics – Drugs vs. NTs – Agonists vs. Antagonists – Receptor types • Tolerance • Specific Neurotransmitter Systems (& drugs that affect them) Pharmacokinetics Pharmacodynamics • Whatever the body does to the drug • Whatever the drug does to the body • how drugs are – absorbed, – distributed within the body, – metabolized, and – excreted. • Main effect: increasing or decreasing the effect of neurotransmitter X • Side effects (unwanted effects) Pharmacokinetics • Sources of administration: oral, intranasal, inhalation, topic, intravenous (i.v), sublingual, intramuscular (i.m.) subcutaneous, intraperitoneal • Distribution: – Lipids (fats) vs. non-lipids (proteins, ionized molecules) • Metabolization: liver • Excretion: kidneys – Half-life: time it takes to eliminate half the drug from the bloodstream. It is used to determine inter-dose interval Ways to administer a drug (& time to reach blood) Dose-response curve: Effect of a drug as a function of the amount of the drug administered. Therapeutic index: The ratio between the dose that produces the desired effect in 50% of the animals and the dose that produces toxic effects in 50% of the animals. Pharmacodynamics • A drug can do only two things, either: – Increase the effect of neurotransmitter X (agonist) – Decrease the effect of neurotransmitter X (antagonist) Thus, in order to understand the action of a ‘drug X’, we need to understand the neurochemical system it interacts with. In other words, we need to understand how Neurotransmitter X - is produced & released from the pre-synaptic neuron - acts on the receptors of the post-synaptic neuron - is removed from the synaptic cleft Pre-synaptic receptors Post-synaptic receptors -- precursors NT ‘x’ 1. produce 2. pack AP Ca++ inflow 3. release 4. Bind ++ 5. Post-synaptic changes (e.g., epsp) 6.A Recycle 6.B Destroy Pre-synaptic Neuron (axon) synaptic cleft Post-synaptic neuron (dendrite) Copyright © Allyn & Bacon 2004 Receptors • Receptors are specific for individual neurotransmitters • More than one receptor for each neurotransmitter. e.g., Acetylcholine (muscarinic & nicotinic receptors) Ionotropic Receptors (e.g., nicotinic) Metabotropic Receptors (e.g., muscarinic) Agonists and Antagonists • Agonist (Greek: Agon, meaning contest) – Substance that facilitates post-synaptic effects • Antagonist – Substance that inhibits or blocks the postsynaptic effects • Exogenous vs. Endogenous (drugs vs. neurotransmitters) • Agonist vs. Antagonist: Both bind to a receptor. The agonist activates it, the antagonist does not (antagonists block the receptor) • Competitive vs. non-competitive: whether the drug works at the same receptor as the NT or at a different receptor as the NT, but one that modifies the NT’s action 1. Will an antagonist produce a rightward shift or a leftward shift in the dose-response curve? (graph) 2. How would a competitive antagonist modify the curve? (draw with a solid line) 3. How would a non-competitive antagonist modify the curve (draw with a dotted line) Tolerance a decreased response due to frequent use. • Metabolic tolerance: faster metabolism of the drug.This is a pharmacokinetic mechanism (e.g., alcohol metabolization by hepatic enzimes) • Cellular-adaptive tolerance: down-regulation of receptors (a pharmacodynamic mechanism) Before drug After Drug Factors that determine the effect of a drug on an individual • • • • • • Age Weight Setting in which the drug is used History of use (tolerance) Level of proteins in blood Time of day drug is consumed • These effects are underlined by both pharmacokinetic and pharmacodynamic modulations